LFVN Stock Overview
Engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
LifeVantage Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$8.60 |
52 Week High | US$8.75 |
52 Week Low | US$4.20 |
Beta | 0.83 |
11 Month Change | 24.10% |
3 Month Change | 14.21% |
1 Year Change | 73.39% |
33 Year Change | 11.91% |
5 Year Change | -29.28% |
Change since IPO | -64.90% |
Recent News & Updates
LifeVantage Corporation (NASDAQ:LFVN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
Aug 15Some Investors May Be Worried About LifeVantage's (NASDAQ:LFVN) Returns On Capital
Aug 02Is There Now An Opportunity In LifeVantage Corporation (NASDAQ:LFVN)?
Jul 15Recent updates
LifeVantage Corporation (NASDAQ:LFVN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
Aug 15Some Investors May Be Worried About LifeVantage's (NASDAQ:LFVN) Returns On Capital
Aug 02Is There Now An Opportunity In LifeVantage Corporation (NASDAQ:LFVN)?
Jul 15LifeVantage Corporation (NASDAQ:LFVN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
May 30The Returns On Capital At LifeVantage (NASDAQ:LFVN) Don't Inspire Confidence
Apr 22When Should You Buy LifeVantage Corporation (NASDAQ:LFVN)?
Mar 27LifeVantage Corporation (NASDAQ:LFVN) Surges 32% Yet Its Low P/S Is No Reason For Excitement
Mar 02LifeVantage (NASDAQ:LFVN) Has Announced A Dividend Of $0.035
Nov 15It Looks Like LifeVantage Corporation's (NASDAQ:LFVN) CEO May Expect Their Salary To Be Put Under The Microscope
Oct 30Returns On Capital At LifeVantage (NASDAQ:LFVN) Paint A Concerning Picture
Jul 18LifeVantage Corporation: Stagnant Sales But Strong Financials To Support The New Dividend
Sep 29Returns On Capital At LifeVantage (NASDAQ:LFVN) Have Stalled
Sep 27LifeVantage declares $0.03 dividend
Aug 23LifeVantage: Soft Quarter, New Dividend Policy, EPS +9% Than Street Expectations
May 05LifeVantage (NASDAQ:LFVN) Might Be Having Difficulty Using Its Capital Effectively
Apr 29Is It Too Late To Consider Buying LifeVantage Corporation (NASDAQ:LFVN)?
Nov 18LifeVantage: 24% Net Cash, 12% FCF Yield And 8x P/E Make This Company Worth A Buy
Sep 23Shareholder Returns
LFVN | US Personal Products | US Market | |
---|---|---|---|
7D | 7.1% | 0.9% | 1.6% |
1Y | 73.4% | -16.1% | 26.4% |
Return vs Industry: LFVN exceeded the US Personal Products industry which returned -17.6% over the past year.
Return vs Market: LFVN exceeded the US Market which returned 25.3% over the past year.
Price Volatility
LFVN volatility | |
---|---|
LFVN Average Weekly Movement | 8.4% |
Personal Products Industry Average Movement | 8.4% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.1% |
10% least volatile stocks in US Market | 3.2% |
Stable Share Price: LFVN's share price has been volatile over the past 3 months.
Volatility Over Time: LFVN's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 248 | Steve Fife | www.lifevantage.com |
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name.
LifeVantage Corporation Fundamentals Summary
LFVN fundamental statistics | |
---|---|
Market cap | US$106.43m |
Earnings (TTM) | US$3.60m |
Revenue (TTM) | US$205.45m |
30.4x
P/E Ratio0.5x
P/S RatioIs LFVN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LFVN income statement (TTM) | |
---|---|
Revenue | US$205.45m |
Cost of Revenue | US$42.49m |
Gross Profit | US$162.97m |
Other Expenses | US$159.37m |
Earnings | US$3.60m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 28, 2024
Earnings per share (EPS) | 0.28 |
Gross Margin | 79.32% |
Net Profit Margin | 1.75% |
Debt/Equity Ratio | 0% |
How did LFVN perform over the long term?
See historical performance and comparison